Premium
Women's programs versus mixed‐gender day treatment: results from a randomized study
Author(s) -
Kaskutas Lee Ann,
Zhang Lixia,
French Michael T.,
Witbrodt Jane
Publication year - 2005
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/j.1360-0443.2005.00914.x
Subject(s) - abstinence , randomized controlled trial , medicine , substance abuse , odds , psychiatry , logistic regression , surgery
ABSTRACT Aims To compare outcomes and costs of out‐patient women's treatment to mixed‐gender programs. Design Randomized clinical trial. Setting Northern California (USA). Intervention Day treatment: one community‐based women's program, two mixed‐gender community‐based programs and one mixed‐gender hospital‐based program. Participants Substance‐dependent women recruited from the community ( n = 122). Measurements Women were interviewed at baseline, at the end of treatment (94% response rate) and at 6 and 12 months post‐treatment (100% response rates). Measures included alcohol and drug use, and psychiatric and social problems. Program costs were estimated using the Drug Abuse Treatment Cost Analysis Program. Findings No significant differences between the women's program and any of the mixed‐gender programs were found for psychiatric problem severity, problems with family and friends or rates of drug use at any of the follow‐up points. Rates of alcohol abstinence and total abstinence were similar between the women's program and both of the mixed‐gender community programs, but were higher at the mixed‐gender hospital program. Only one of these results was replicated in the multivariate analysis, with the odds of total abstinence significantly lower for those randomized to the women's program than the mixed‐gender hospital program. However, the average cost of a treatment episode was significantly higher at the hospital program than at the women's program ($1212 versus $543). Conclusions These findings suggest that female substance abusers may be treated as effectively in mixed‐gender programs as in women's programs.